Product: FGFP1 Antibody
Catalog: DF2498
Description: Rabbit polyclonal antibody to FGFP1
Application: WB IHC
Reactivity: Human
Prediction: Bovine
Mol.Wt.: 26kDa; 26kD(Calculated).
Uniprot: Q14512
RRID: AB_2839704

View similar products>>

   Size Price Inventory
 100ul $280 In stock
 200ul $350 In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Product Info

Source:
Rabbit
Application:
WB 1:500-1:2000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Reactivity:
Human
Prediction:
Bovine(86%)
Clonality:
Polyclonal
Specificity:
FGFP1 Antibody detects endogenous levels of total FGFP1.
RRID:
AB_2839704
Cite Format: Affinity Biosciences Cat# DF2498, RRID:AB_2839704.
Conjugate:
Unconjugated.
Purification:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
Storage:
Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
Alias:

Fold/Unfold

17 kDa HBGF-binding protein; 17 kDa heparin binding growth factor binding protein; 17 kDa heparin-binding growth factor-binding protein; FGF binding protein 1; FGF BP; FGF BP1; FGF-binding protein 1; FGF-BP; FGF-BP1; FGFBP; FGFBP-1; Fgfbp1; FGFP1_HUMAN; Fibroblast growth factor binding protein 1 precursor; Fibroblast growth factor-binding protein 1; HBp17;

Immunogens

Immunogen:
Uniprot:
Gene(ID):
Expression:
Q14512 FGFP1_HUMAN:

Expressed in the suprabasal region of the epidermis, in hair follicles, the basement membrane at the dermo-epidermal junction (occasionally extending into the basement membrane of dermal blood vessels), wounded skin and several invasive squamous cell carcinomas (at protein level). Expressed in normal and wounded skin and various squamous cell carcinomas.

Sequence:
MKICSLTLLSFLLLAAQVLLVEGKKKVKNGLHSKVVSEQKDTLGNTQIKQKSRPGNKGKFVTKDQANCRWAATEQEEGISLKVECTQLDHEFSCVFAGNPTSCLKLKDERVYWKQVARNLRSQKDICRYSKTAVKTRVCRKDFPESSLKLVSSTLFGNTKPRKEKTEMSPREHIKGKETTPSSLAVTQTMATKAPECVEDPDMANQRKTALEFCGETWSSLCTFFLSIVQDTSC

Predictions

Predictions:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Bovine
86
Pig
75
Horse
0
Sheep
0
Dog
0
Xenopus
0
Zebrafish
0
Chicken
0
Rabbit
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

PTMs - Q14512 As Substrate

Site PTM Type Enzyme
S37 O-Glycosylation
T46 O-Glycosylation
K57 Acetylation
T73 O-Glycosylation
S80 Phosphorylation
T179 O-Glycosylation
T180 O-Glycosylation
S182 O-Glycosylation
T187 O-Glycosylation
T189 O-Glycosylation
T192 O-Glycosylation

Research Backgrounds

Function:

Acts as a carrier protein that release fibroblast-binding factors (FGFs) from the extracellular matrix (EM) storage and thus enhance the mitogenic activity of FGFs. Enhances FGF2 signaling during tissue repair, angiogenesis and in tumor growth.

Subcellular Location:

Secreted>Extracellular space. Cell membrane>Peripheral membrane protein.
Note: Extracellular and plasma membrane-associated. Colocalizes with HSPG2 in the pericellular environment of squamous cell carcinomas.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
Tissue Specificity:

Expressed in the suprabasal region of the epidermis, in hair follicles, the basement membrane at the dermo-epidermal junction (occasionally extending into the basement membrane of dermal blood vessels), wounded skin and several invasive squamous cell carcinomas (at protein level). Expressed in normal and wounded skin and various squamous cell carcinomas.

Subunit Structure:

Found in a complex with FGFBP1, FGF1 and FGF2. Interacts with FGF1, FGF2, FGF7, FGF10, FGF22 and HSPG2.

Family&Domains:

Belongs to the fibroblast growth factor-binding protein family.

References

1). FGFBP1-mediated crosstalk between fibroblasts and pancreatic cancer cells via FGF22/FGFR2 promotes invasion and metastasis of pancreatic cancer. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021 (PubMed: 34117747) [IF=3.3]

Application: WB    Species: Human    Sample: PANC-1 and Mia PaCa-2 cells

Figure 1. FGFBP1 silencing in PCCs decreased the expression and secretion of FGF22 in human CAFs cocultured with PCCs (A) Efficiency of FGFBP1 knockdown in PANC-1 and Mia PaCa-2 cells evaluated by qRT-PCR. (B) Efficiency of FGFBP1 knockdown in PANC-1 and Mia PaCa-2 cells evaluated by western blot analysis. (C) Heat map of differentially expressed genes in mouse fibroblasts cocultured with FGFBP1-shRNA-transfected PANC-1 cells compared with mouse fibroblasts cocultured with scramble-transfected PANC-1 cells. (D) mRNA level of FGF22 in human CAFs cocultured with FGFBP1-shRNA-transfected PANC-1 or Mia PaCa-2 cells (CAF-P or CAF-M) compared with that in CAFs cocultured with scramble-transfected PANC-1 or Mia PaCa-2 cells. (E) Protein level of FGF22 in CAF-P or CAF-M compared with that in CAFs cocultured with scramble-transfected PANC-1 or Mia PaCa-2 cells are shown. (F) Secretion of FGF22 in culture medium of CAF-P or CAF-M compared with that in culture medium of CAFs cocultured with scramble-transfected PANC-1 or Mia PaCa-2 cells.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.